Aisling Capital Management’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Hold |
|
|||||
|
2025
Q1 | $735K | Hold |
|
|||||
|
2024
Q4 | $1.59M | Hold |
|
|||||
|
2024
Q3 | $1.7M | Hold |
|
|||||
|
2024
Q2 | $7.65M | Hold |
|
|||||
|
2024
Q1 | $14.5M | Hold |
|
|||||
|
2023
Q4 | $1.52M | Hold |
|
|||||
|
2023
Q3 | $1.88M | Hold |
|
|||||
|
2023
Q2 | $4.31M | Hold |
|
|||||
|
2023
Q1 | $5.39M | Hold |
|
|||||
|
2022
Q4 | $2.69M | Hold |
|
|||||
|
2022
Q3 | $3.2M | Hold |
|
|||||
|
2022
Q2 | $3.97M | Hold |
|
|||||
|
2022
Q1 | $7.14M | Hold |
|
|||||
|
2021
Q4 | $17.1M | Hold |
|
|||||
|
2021
Q3 | $22.1M | Hold |
|
|||||
|
2021
Q2 | $38.5M | Buy |
|